Literature DB >> 28013103

Ebola virus VP35 blocks stress granule assembly.

Valerie Le Sage1, Alessandro Cinti2, Stephen McCarthy3, Raquel Amorim2, Shringar Rao4, Gian Luca Daino5, Enzo Tramontano5, Donald R Branch3, Andrew J Mouland6.   

Abstract

Stress granules (SGs) are dynamic cytoplasmic aggregates of translationally silenced mRNAs that assemble in response to environmental stress. SGs appear to play an important role in antiviral innate immunity and many viruses have evolved to block or subvert SGs components for their own benefit. Here, we demonstrate that intracellular Ebola virus (EBOV) replication and transcription-competent virus like particles (trVLP) infection does not lead to SG assembly but leads to a blockade to Arsenite-induced SG assembly. Moreover we show that EBOV VP35 represses the assembly of canonical and non-canonical SGs induced by a variety of pharmacological stresses. This SG blockade requires, at least in part, the C-terminal domain of VP35. Furthermore, results from our co-immunoprecipitation studies indicate that VP35 interacts with multiple SG components, including G3BP1, eIF3 and eEF2 through a stress- and RNA-independent mechanism. These data suggest a novel function for EBOV VP35 in the repression of SG assembly.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ebola virus; In vitro GST binding assay; Poliovirus infection; Proximity ligation assay; Stress granule assembly; TIAR recruitment; VP35; trVLP infection

Mesh:

Substances:

Year:  2016        PMID: 28013103     DOI: 10.1016/j.virol.2016.12.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

Review 1.  Filovirus Strategies to Escape Antiviral Responses.

Authors:  Judith Olejnik; Adam J Hume; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler; Elke Mühlberger
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

2.  The Amino Acid at Position 95 in the Matrix Protein of Rabies Virus Is Involved in Antiviral Stress Granule Formation in Infected Cells.

Authors:  Isshu Kojima; Koji Onomoto; Wenjie Zuo; Makoto Ozawa; Kosuke Okuya; Kiyotada Naitou; Fumiki Izumi; Misuzu Okajima; Takuro Fujiwara; Naoto Ito; Mitsutoshi Yoneyama; Kentaro Yamada; Akira Nishizono; Makoto Sugiyama; Takashi Fujita; Tatsunori Masatani
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

3.  Porcine Epidemic Diarrhea Virus Infection Subverts Arsenite-Induced Stress Granules Formation.

Authors:  Xiaozhen Guo; Kejian Yu; Zhonghao Xin; Liping Liu; Yuehua Gao; Feng Hu; Xiuli Ma; Kexiang Yu; Yufeng Li; Bing Huang; Zhengui Yan; Jiaqiang Wu
Journal:  Front Microbiol       Date:  2022-07-04       Impact factor: 6.064

Review 4.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

Review 5.  Translational Control in Virus-Infected Cells.

Authors:  Noam Stern-Ginossar; Sunnie R Thompson; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

6.  Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking.

Authors:  Anne Monette; Meijuan Niu; Lois Chen; Shringar Rao; Robert James Gorelick; Andrew John Mouland
Journal:  Cell Rep       Date:  2020-04-21       Impact factor: 9.423

7.  HIV-1 NC-induced stress granule assembly and translation arrest are inhibited by the dsRNA binding protein Staufen1.

Authors:  Shringar Rao; Alessandro Cinti; Abdelkrim Temzi; Raquel Amorim; Ji Chang You; Andrew J Mouland
Journal:  RNA       Date:  2017-11-10       Impact factor: 4.942

8.  Inclusion bodies of human parainfluenza virus type 3 inhibit antiviral stress granule formation by shielding viral RNAs.

Authors:  Zhulong Hu; Yuang Wang; Qiaopeng Tang; Xiaodan Yang; Yali Qin; Mingzhou Chen
Journal:  PLoS Pathog       Date:  2018-03-08       Impact factor: 6.823

9.  Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives.

Authors:  Shawn Goyal; Beth Binnington; Stephen D S McCarthy; Didier Desmaële; Laurent Férrié; Bruno Figadère; Philippe M Loiseau; Donald R Branch
Journal:  F1000Res       Date:  2020-04-17

10.  Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA Synthesis.

Authors:  Jingru Fang; Colette Pietzsch; Palaniappan Ramanathan; Rodrigo I Santos; Philipp A Ilinykh; Mariano A Garcia-Blanco; Alexander Bukreyev; Shelton S Bradrick
Journal:  MBio       Date:  2018-10-09       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.